Add Row
Add Element
cropper
update

Provider Impact

update
Add Element
  • Home
  • Categories
    • Medicare + RTM
    • Pharmacy Insights
    • Provider Spotlights
    • HR & Staff Benefits
Add Row
Add Element
June 17.2025
3 Minutes Read

Understanding the Cannabis-CVD Link: Insights for Healthcare Providers

Cannabis dispensary worker measuring cannabis, highlighting cardiovascular risk.

The Complicated Connection Between Cannabis and Heart Health

As discussions around cannabis legalization and medical use continue to evolve, recent research sheds crucial light on the potential impacts of cannabis consumption on cardiovascular health. A meta-analysis encompassing 24 observational studies has confirmed that users of cannabis face increased risks of significant cardiovascular events.

The findings, published in the journal Heart, reveal that cannabis users may be more susceptible to conditions such as acute coronary syndrome, stroke, and cardiovascular death. Specifically, the report identified a relative risk (RR) of 1.29 for acute coronary syndrome, 1.20 for stroke, and a staggering 2.10 for cardiovascular death. These figures indicate a substantial concern for healthcare professionals and patients alike as cannabis use becomes more prevalent.

Changing Patterns of Cannabis Use

The study also emphasizes how the profile of cannabis users has shifted dramatically in recent years. As cannabis laws liberalize across many states and countries, a surge in cannabis potency has been observed, with products today often containing higher levels of delta-9-tetrahydrocannabinol (THC). This trend has raised questions about how newer consumption habits and product formulations may contribute to cardiovascular risk.

Experts like Emilie Jouanjus, PharmD, PhD, highlight that understanding the nuances of cannabis consumption—such as the method of use and product potency—is essential in clarifying its health implications. Higher potency products are linked to more frequent and problematic use patterns, making it crucial for healthcare providers to consider these factors in patient evaluations.

Incorporating Cannabis Education in Clinical Settings

Leading researchers Stanton Glantz, PhD, and Lynn Silver, MD, MPH, advocate for a comprehensive approach in clinical settings, where healthcare professionals routinely inquire about cannabis use. This proactive approach could not only improve patient education regarding the risks associated with cannabis but also ensure that clinicians make informed decisions about care that align with contemporary risks.

According to their perspectives, just as tobacco and alcohol are scrutinized in clinical practice, cannabis should also be part of routine discussions. Emphasizing the need for education in professional environments aligns with the urgent call for healthcare reform aimed at improving public health outcomes.

Counterarguments and Diverse Perspectives on Cannabis Regulation

While the meta-analysis findings underscore significant risks, there are varying perspectives within the debate about cannabis. Proponents of cannabis tout its therapeutic benefits for chronic pain relief, anxiety, and other medical conditions. Understanding these diverse viewpoints is critical for creating balanced healthcare policies that protect public health while recognizing the medicinal capabilities of cannabis.

Furthermore, communication strategies in healthcare need to reflect a commitment to informed choices, ensuring that patients are aware of both the potential risks and benefits associated with cannabis use. This holistic approach may prove pivotal in the ongoing discourse about cannabis consumption, especially as it becomes more ingrained in societal norms.

Future Directions in Cannabis Research and Health Policy

As cannabis consumption continues to rise, future research is imperative to deciphering its long-term health implications. Policymakers and healthcare leaders must prioritize rigorous investigations into the effects of cannabis on various health outcomes, particularly cardiovascular health. Such research will enable healthcare providers to make evidence-based recommendations and guide patients effectively.

Moreover, health authorities must consider regulatory frameworks that address the growing demand for cannabis products while ensuring public safety. Effective regulation could involve scrutinizing product potency, accessibility, and marketing strategies, similar to tobacco regulations. Protecting bystanders from secondhand exposure should also remain a key concern.

Conclusion: Navigating the Landscape of Cannabis Risks and Benefits

In conclusion, the evolving landscape of cannabis use presents both opportunities and challenges for healthcare providers. As the evidence base grows, understanding the risks associated with cannabis use in the context of cardiovascular health becomes essential for evidence-based practice. It is crucial for healthcare professionals to engage in meaningful conversations surrounding cannabis, balancing its therapeutic potential with its associated health risks. By doing so, they can contribute to a future where informed decisions about cannabis can lead to safer consumption patterns and improved health outcomes.

To stay abreast of the latest medical news and insights, healthcare professionals are encouraged to participate in continued education opportunities and to engage with emerging research in this dynamic field.

Provider Spotlights

0 Views

0 Comments

Write A Comment

*
*
Related Posts All Posts
06.18.2025

Maine's Innovative Shift: Physician Associate Title Adoption Explained

Update Legislation Transformation: The Rise of the 'Physician Associate' In a groundbreaking move for healthcare professionals, Maine has officially changed the title of “physician assistant” to “physician associate,” making it the second state in the U.S. to adopt this term. Passed on June 2 and enacted on June 16, the legislative change marks a significant step forward in the identity and recognition of physician associates. This shift comes after two years of dedicated advocacy by the Maine Academy of Physician Associates, reflecting a growing acceptance of the evolving role these professionals play in the evolving landscape of healthcare. The Advocacy Behind the Title Change Kathleen Moneghan, PA-C, vice president of the association, expressed excitement about the change, emphasizing its potential to enhance patient relationships. “It is an exciting time to be a PA, and we can’t wait to see the positive change this has with our patients and with our role in the healthcare system,” she stated in a release. This enthusiasm echoes the sentiments of physician associates nationwide, as it aligns with a broader effort to enhance their stature within healthcare teams, ultimately leading to better patient care. Understanding Why This Matters The change from “physician assistant” to “physician associate” is more than just a title change; it’s a reflection of the shifting dynamics of healthcare roles. Increasingly, healthcare practices are recognizing that the professional contributions of physician associates go well beyond traditional support roles. They are often involved in decision-making processes and direct patient care, making them essential team members that enhance practice efficiency solutions and overall patient engagement tools. Looking Ahead: The Future of Physician Associates While Oregon took the initiative to become the first state to officially adopt the term in April 2024, the path to further acceptance at the state and federal levels is anticipated to be a long one. The American Association of Physician Associates (AAPA), which officially adopted the term in 2021, acknowledges that while many state chapters have embraced the title, navigating the legal landscape can be challenging. As we look towards the future, it's crucial for stakeholders in the healthcare system to consider how this change can positively impact workforce dynamics, such as improving employee health benefits and enhancing clarity on Medicare reimbursement rates for their services. Impact on Healthcare Delivery: A Closer Examination The introduction of the “physician associate” designation has implications not just for professional identities but also for the healthcare delivery system as a whole. By redefining roles and promoting a clearer understanding of responsibilities, practices can foster better collaboration and improve patient care. Enhancements in practice automation, particularly in telehealth revenue generation and voice AI agents for patient communications, will further support the new roles that physician associates can play. This collaborative approach encourages a comprehensive view of healthcare that prioritizes both efficiency and quality, ultimately benefiting all stakeholders involved. Building a Community of Physician Associates The movement to enhance the title and identity of physician associates is also a testament to the strength of community and professional alliances. Peer groups, networking initiatives, and continued education among healthcare providers can facilitate knowledge exchange, empower advocacy for legislative changes, and promote best practices in patient care, pharmacy profitability, and practice revenue optimization. The support for each other will not only enhance individual practices but will serve as a foundation for a robust healthcare community committed to innovation and excellence. Create Impactful Change: Take Action Today As the landscape of health care evolves, so too should the roles within it. The changes being made in titles and responsibilities open new doors for patient-centric care and enhanced professional satisfaction. Health organizations and practices should not only adopt these changes but actively champion the professional development of physician associates. Advocates are encouraged to engage in discussions on this topic, suggesting practical insights for integrating these professionals into their teams. Collectively, we can leverage the excitement surrounding these changes to create impactful structural improvements in the healthcare system.

06.18.2025

Rebuild Drug Manufacturing Infrastructure to Alleviate Shortages for Patients and Providers

Update Rebuilding America’s Drug Manufacturing LandscapeIn a significant move toward resolving the ongoing medicine shortages, a bipartisan group of U.S. senators has reintroduced the Rolling Active Pharmaceutical Ingredient and Drug Reserve Act. Senators Gary Peters (D-Mich.), Marsha Blackburn (R-Tenn.), Tim Kaine (D-Va.), and Ted Budd (R-N.C.) aim to expand the manufacturing capacity and stockpiles of essential medications in the United States and its allies. This initiative comes at a critical juncture, as a recent report indicates that at least 15 medications have faced shortages for more than a decade, raising alarms over the implications for healthcare accessibility.Why This Bill Matters: Understanding the Shortage CrisisThe pressing issue of drug shortages affects many healthcare providers, including independent physicians and community pharmacists, who rely on a steady supply of medications. Generic drugs, often cheaper and preferred for their cost-efficient nature, can be complex to manufacture, leading to supply chain challenges. For many practitioners in rural and underserved areas, these shortages can severely limit patient care, impacting both health outcomes and practice revenue.What the New Legislation Will DoThe proposed legislation requires the Department of Health and Human Services (HHS) to award contracts to U.S. manufacturers or trusted allies, ensuring that they maintain adequate stockpiles of essential medications and ingredients. This shift not only aims to fortify healthcare infrastructure but also puts a premium on local manufacturing, potentially boosting pharmacy profitability and enhancing patient access.Insights into Manufacturing and ComplianceIn conjunction with expanding federal stockpiles, the legislation includes a mandate for the Government Accountability Office to investigate the status of unused domestic manufacturing capabilities. This could lead to creating new job opportunities and support healthcare automation, as facilities improve their processes to align with modern practices. For independent pharmacies and clinics, understanding their operational compliance with such legislation could also uncover new pathways for financial optimization and employee benefits.Potential Impact on Healthcare ProfessionalsFor independent healthcare professionals and small practices, a reliable supply of medications could mean a restoration of trust with their patients. By addressing issues around Medicare reimbursement and improving remote therapeutic monitoring (RTM) programs, healthcare providers can improve their service delivery. Enhanced pharmacy profitability and patient engagement tools can lead to a more sustainable practice, allowing medical staff to focus on what they do best—caring for their patients.Future Predictions and OpportunitiesLooking ahead, if this legislation passes, it is expected to not just stabilize the short-term medication supply but also create long-lasting benefits through improved healthcare compliance standards and practice efficiency solutions. As the healthcare landscape evolves, independent providers may find themselves embracing innovative strategies, including digital front desks and telehealth revenue models, to meet their patient's needs effectively.Actionable Insights for Healthcare StakeholdersHealthcare professionals should consider how this legislation can help them optimize their practices and diversify their revenue streams. Implementing practices that enhance patient care will not only be vital for compliance but can significantly affect medical billing recovery and coping with insurance underpayments. By proactively adapting to these upcoming changes, healthcare systems can better position themselves to thrive amidst shifts in legislation and market demands.As the debate on drug shortages and manufacturing infrastructure heats up in Congress, it is crucial for all stakeholders—from independent clinicians to pharmacy owners—to stay informed and engaged. This bill presents an opportunity not only to improve patient care but also to enhance practice sustainability in a rapidly changing industry.

06.17.2025

Telehealth Geriatric Cancer Assessment: A New Era in Care for Seniors

Update A Breakthrough in Telehealth for Seniors with CancerThe landscape of healthcare for older adults battling cancer is undergoing a significant transformation, thanks in large part to innovative telehealth solutions. A groundbreaking study conducted in Brazil has revealed that telehealth-managed Geriatric Assessment and Integrated Interventions (GAIN-S) remarkably enhances outcomes for elderly cancer patients living in low-resource settings. This randomized trial is the first of its kind to demonstrate such efficacy, signaling a pivotal advancement in healthcare accessibility.Improving Quality of Life for PatientsAccording to the study led by Dr. William Dale and his colleagues, the telehealth GAIN-S intervention yielded substantial improvements in patients’ physical functions, psychological well-being, and overall quality of life (QoL) within just three months. Moreover, patients reported feeling less burdened by their symptoms and gained a deeper understanding of their conditions and prognosis. This is particularly valuable in regions where cancer care resources are scarce and challenging to access.By integrating geriatric assessments remotely, the research indicates a shift toward more inclusive healthcare delivery. Patients no longer need to endure lengthy travels to cancer centers — expertise is brought directly to them via their homes. As Dr. Dale poignantly expressed, “It was a win-win for patients, families, and providers,” highlighting the dual benefits of equity in access to care and resource optimization.Amplifying Impact Beyond High-Income RegionsThe findings from this study are particularly significant as they encourage expanding geriatric assessment programs globally, especially into low- and middle-income countries (LMICs). Dr. Martine Extermann underscores the implications, stating that Geriatric Assessment and Management (CGAM) should not be confined to affluent demographics. Instead, the model should be adopted in high-income areas struggling with resource distribution, notably in rural and underprivileged regions.Collective Momentum Towards Health EquityThe progress shown here is not merely a medical achievement, but also a step towards reducing health disparities that affect older patients worldwide. Dr. Extermann highlights how the study fosters the goal of providing personalized cancer care tailored to each patient's unique needs. With ongoing research and implementation, CGAM has the potential to evolve from a luxury service to a commonplace standard across various healthcare environments.What’s Next for Telehealth in OncologyAs healthcare evolves, the role of telemedicine is becoming more prominent, especially in the oncology field. The encouraging data from the Brazilian study calls for further research, particularly concerning the optimization and delivery of integrated care models for aging populations. The upcoming trials and studies can serve to solidify the role of telehealth in routine geriatric assessments, ultimately paving the way for broader adoption and integration into everyday practice.Concluding Thoughts and Future DirectionsThis innovative approach to elder cancer care exemplifies not only the potential of medical technology but also its compassionate application. By reducing the burdens of travel and enhancing patient-provider interactions through technology, the healthcare sector is gradually making strides toward equity in access to quality care for all. Stakeholders across the healthcare domain—physicians, administrators, and policymakers—must rally around these findings, championing telehealth solutions to extend their reach further into underserved populations.Are you a healthcare provider looking to learn more about the latest in telehealth and geriatric care? Stay informed and explore how to leverage these advancements in your practice to improve patient outcomes and enhance the quality of care you deliver.

Add Row
Add Element
cropper
update
Provider Impact
cropper
update

Provider Impact is a news and insights platform for healthcare professionals—covering policy, innovation, and business trends that shape the care industry.

  • update
  • update
  • update
  • update
  • update
  • update
  • update
Add Element

COMPANY

  • Privacy Policy
  • Terms of Use
  • Advertise
  • Contact Us
  • Menu 5
  • Menu 6
Add Element

+19493753833

AVAILABLE FROM 8AM - 5PM

Huntington Beach CA

Add Element

ABOUT US

Provider Impact brings together trusted reporting, expert voices, and healthcare industry updates in one dedicated space. Our goal is to keep providers informed and connected to the trends and decisions that impact their work and their patients.

Add Element

© 2025 CompanyName All Rights Reserved. Address . Contact Us . Terms of Service . Privacy Policy

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*